Starpharma Holdings Limited
Save
–
Market cap
–
Current P/E
344.83x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray.
Similar securities
Based on sector and market capitalization
Report issue